glp-1 drugs overview Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans Mapping the effectiveness and risks

Monitoring: Treatment should be guided by a qualified provider who monitors responses and adjusts course as needed

For a 75kg (165lb) person, this suggests 2.25 to 3.75mg daily, aligning with the 10 to 20 unit range at 20mg/mL concentration

These patients should have liver function testing at baseline, 1 month, and 3 months after starting either agent

Too much NNMT can lower levels of NAD+, leading to weaker muscles and poorer muscle function as you age

A retrospective study of 12,000 (6,000 male and 6,000 female) breastfed neonates in Greece found that carnitine and it various esters in the serum of 3-day-old infants was related to their birth weight

Directions for Consumption (Approximation) 1